US · USD
LGND
Ligand Pharmaceuticals Incorporated
- Day's range
- $292.47 – $301.27
- Day's volume
- $90.7M
- 52-week range
- $177.73 – $322.61
Follow LGND in the Fuolio
See how LGND weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountLGND in numbers
- Market cap
- $5.8B
- P/E
- 29.64
- P/B
- 6.04
- Dividend yield (12m)
- 0.00%
- Net debt/EBITDA
- -1.81
LGND trades at 29.64 times its earnings of the last 12 months.
LGND price history
LGND risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +44.34% | +402.93% | +190.33% |
| Volatility (annualized) | 42.50% | 40.30% | 41.17% |
| Largest drawdown | -10.12% | -16.40% | -48.23% |
| Positive months | 7/12 | 23/36 | 35/60 |
How much did investing in LGND return?
$1,000.00 invested on 11/01/2021 would be worth $2,903.26 today.
- Value today in LGND
- $2,903.26
- Return over the period
- +190.33%
- Return per year
- +24.13%
- In the S&P 500
- $1,708.29
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
LGND fundamentals
Valuation
- P/E29.64
- P/B6.04
- EV/EBITDA43.99
- EV/EBIT59.27
- EV/Revenue19.33
- P/EBIT61.71
- P/S20.12
- P/OCF44.39
- P/FCF44.48
- Earnings yield1.69%
- PEG ratio—
- Earnings per share$9.89
- Book value per share$48.53
Debt
- Net debt-$231.2M
- Net debt/EBITDA-1.81
- Net debt/Equity-0.24
- Debt/Equity1.16
- Current ratio31.18
- Quick ratio30.96
- Cash ratio29.05
Efficiency
- Gross margin—
- EBITDA margin43.93%
- Operating margin32.61%
- Net margin67.88%
- Asset turnover0.13
Profitability
- ROE20.38%
- ROA9.02%
- ROIC10.66%
- Payout0.00%
Growth
- Revenue CAGR (5 years)4.13%
- Earnings CAGR (5 years)32.72%
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
What is LGND's fair price?
Two classic value formulas, with today's numbers. The current price is $293.26.
- Graham's fair price
- $103.94
- 64.56% below the price
√(22.50 × $9.89 × $48.53)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- —
- Does not apply to LGND: it paid no distributions in the last five years.
Décio Bazin only bought stocks yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years over 6%.
Graham ignores growth and debt; Bazin assumes past distributions repeat. They are references to compare, not a buy recommendation.
LGND's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 30.29 | -511.71 | 24.25 | -34.19 | 45.56 | -553.47 | 2.74 | 19.36 |
| P/B | 3.71 | 2.48 | 1.80 | 1.91 | 3.17 | 2.33 | 2.24 | 4.95 |
| EV/EBITDA | 50.42 | 163.32 | 26.09 | 20.90 | 16.80 | 26.14 | 2.09 | 15.72 |
| Earnings per share | $6.24 | -$0.21 | $2.95 | -$1.95 | $3.39 | -$0.18 | $38.13 | $7.01 |
| Book value per share | $51.01 | $43.13 | $39.59 | $34.99 | $48.73 | $42.71 | $46.48 | $27.43 |
| ROE | 12.23% | -0.49% | 7.44% | -5.58% | 6.96% | -0.42% | 82.02% | 25.55% |
| ROIC | 3.16% | -0.00% | 1.44% | 0.00% | 12.65% | 5.29% | 83.10% | 24.14% |
| Gross margin | — | — | — | — | — | — | — | 97.48% |
| EBITDA margin | 27.89% | 7.56% | 36.91% | 27.81% | 64.14% | 38.63% | 686.25% | 70.20% |
| Net margin | 46.42% | -2.41% | 39.72% | -17.00% | 23.66% | -1.82% | 523.19% | 57.00% |
LGND's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $268.1M | $167.1M | $131.3M | $196.2M | $241.5M | $163.6M |
| Cost of revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| EBITDA | $74.8M | $12.6M | $48.5M | $54.6M | $154.9M | $63.2M |
| EBIT | $41M | -$22.6M | $11.9M | $3M | $103.9M | $37.5M |
| Financial result | $118M | $25.1M | $51.7M | $33M | -$31.6M | -$36.2M |
| Income before tax | $159M | $2.5M | $63.7M | $36M | $72.2M | $1.3M |
| Income tax | -$34.5M | -$6.6M | -$9.8M | -$41.2M | $4.1M | $5.3M |
| Net income | $124.5M | -$4M | $52.2M | -$33.4M | $57.1M | -$3M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does LGND pay dividends?
LGND has no distributions on record.
About Ligand Pharmaceuticals Incorporated
- Sector
- Manufacturing
Questions about LGND
How much is LGND today?
LGND is at $293.26 (-1.24% on the day), last traded on 10/07/2026.
What are the P/E and P/B of LGND?
LGND trades at a P/E of 29.64 and a P/B of 6.04.
How much did LGND return in 12 months?
LGND returned 44.34% in 12 months, with annualized volatility of 42.50% and a largest drawdown of -10.12%.